The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Emel’yanov A.V.

Department of Cardiovascular Surgery, Russian Cardiology Research and Production Complex, Moscow, Russia

Avdeev S.N.

I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russia, Moscow, Russia, 119991;
Pulmonology Research Institute under the Federal Medical and Biological Agency of Russia, Moscow, Russia, 115682

Aisanov Z.R.

Pulmonology Research Institute, Moscow, Russia

Vizel A.A.

Department of Phtisiopulmonology, Kazan State Medical University, Ministry of Health of Russia, Kazan, Russia

Ilina N.I.

National research center «Institute of Immunology» Federal medical-biological agency, Moscow, Russia

Knyazheskaya N.P.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia

Leshchenko I.V.

Ural'skaia gosudarstvennaia meditsinskaia akademiia Minzdrava Rossii;
Meditsinskoe ob''edinenie "Novaia bol'nitsa", Ekaterinburg

Nenasheva N.M.

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow, Russia

Styrt E.A.

Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia, Moscow, Russia

Titova O.N.

NII pul'monologii GOU VPO «Pervyj Sankt-Peterburgskij gosudarstvennyj meditsinskij universitet im. akad. I.P. Pavlova», Sankt-Peterburg, Rossija, 197022

Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas

Authors:

Emel’yanov A.V., Avdeev S.N., Aisanov Z.R., Vizel A.A., Ilina N.I., Knyazheskaya N.P., Leshchenko I.V., Nenasheva N.M., Styrt E.A., Titova O.N.

More about the authors

Journal: Therapeutic Archive. 2016;88(8): 135‑137

Read: 1389 times


To cite this article:

Emel’yanov AV, Avdeev SN, Aisanov ZR, et al. . Expert Panel Resolution on Personified Choice of an Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Diseas. Therapeutic Archive. 2016;88(8):135‑137. (In Russ.)
https://doi.org/10.17116/terarkh2016888135-137

References:

  1. Canonica GW, Arp J, Keegstra JR, Chrystyn H. Spiromax, a new dry powder inhaler: dose consistency under simulated real-world conditions. J Aerosol Med Pulm Drug Deliv. 2015;28:309-319. doi:10.1089/jamp.2015.1216
  2. Chrystyn H, Dekhuijzen R, Rand C, Bosnic-Anticevich S, Roche N, Lavorini F, Thomas V, Steele J, Raju P, Freeman D, Small I, Canvin J, Price D. Evaluation of Inhaler Technique Mastery for Budesonide Formoterol Spiromax compared with Symbicort Turbohaler in Adult Patients with Asthma Primary Results From the Easy Low Instruction Over Time [ELIOT] Study. Presented at BTS Winter Meeting 2015. Poster number P154. doi:10.1136/thoraxjnl-2015-207770.291
  3. Sandler N, Hollander J, Langstrom D, Santtila P, Saukkonen A, Torvinen S. Evaluation of Inhaler Technique Mastery and Handling Errors With Spiromax, Easyhaler, And Turbuhaler Devices (Finhaler). Value in health. 2015. doi:10.1016/j.jval.2015.09.707
  4. Azouz W, Chetcuti P, Hosker H, Saralaya D, Chrystyn H. Inhalation characteristics of asthma patients, COPD patients and healthy volunteers with the Spiromax and Turbuhaler devices: a randomized, cross-over study. BMC Pulm Med. 2015;15:47. doi:10.1186/s12890-015-0043-x
  5. Virchow JC, Gopalan G, Rodriguez-Roisin R, Shu Y. Efficacy and safety of budesonide-formoterol (BF) Spiromax in adults and adolescents with asthma: randomised comparison with BF Turbuhaler. Thorax. 2014;69(Suppl. 2):Poster Number 227. (Presented at the BTS WINTER MEETING, London, UK, 03-05 December 2014). doi:10.1136/thoraxjnl-2014-206260.355
  6. Weisfeld L, Shu Y, Shah TP. Bioequivalence of budesonide plus formoterol (BF) Spiromax and BF Turbuhaler (with and without charcoal block) in healthy volunteers. Int J Clin Pharmacol Ther. 2015;53:593-602. doi:org/10.5414/cp202238
  7. Virchow JC, Rodriguez-Roisin R, Papi A, Shah TP, Gopalan G. A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax compared to budesonide-formoterol Turbuhaler in adults and adolescents with persistent asthma. BMC Pulm Med. 2016;16:42. doi:10.1186/s12890-016-0200-x
  8. Plusa T, Bijos P. Features of an ideal inhaler in testing a new inhaler device. Int Rev Allergol Clin Immunol Family Med. 2015;XXI/1:021-024.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.